N/A
Manufactured by Cosette Pharmaceuticals, Inc.
14,129 FDA adverse event reports analyzed
Last updated: 2026-04-14
PRASUGREL HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Cosette Pharmaceuticals, Inc.. The most commonly reported adverse reactions for PRASUGREL HYDROCHLORIDE include MYOCARDIAL INFARCTION, GASTROINTESTINAL HAEMORRHAGE, CHEST PAIN, HAEMORRHAGE, DYSPNOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PRASUGREL HYDROCHLORIDE.
Out of 9,953 classified reports for PRASUGREL HYDROCHLORIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 14,129 FDA FAERS reports that mention PRASUGREL HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include MYOCARDIAL INFARCTION, GASTROINTESTINAL HAEMORRHAGE, CHEST PAIN, HAEMORRHAGE, DYSPNOEA, CONTUSION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Cosette Pharmaceuticals, Inc. in connection with PRASUGREL HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.